ALMIRALL, S.A. «...1112131415...» Page 11 out of 18 14/12/2021 08:04 ALMIRALL, S.A. Other relevant information Almirall and Ichnos Science Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody Register number: 13166 15/11/2021 07:03 ALMIRALL, S.A. On business and financial situation Almirall files 3rd Quarter results presentation for 2021 Register number: 12748 15/11/2021 06:55 ALMIRALL, S.A. On business and financial situation Almirall announces that will webcast a conference to introduce and explain the results for the third quarter of 2021. Register number: 12747 01/11/2021 08:01 ALMIRALL, S.A. Other relevant information AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma. Register number: 12510 05/10/2021 17:32 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el tercer trimestre de 2021 Register number: 12065 22/09/2021 12:41 ALMIRALL, S.A. On financial instruments Almirall, S.A. of its 2.125 % senior notes in an aggregate principal amount of €300,000,000 due 2026 has successfully been closed and paid Register number: 11778 15/09/2021 18:05 ALMIRALL, S.A. On financial instruments Almirall has successfully completed the pricing of the issuance of senior notes in an aggregate principal amount of €300 million due 2026 Register number: 11684 Related to communication no. 11601 dated 13/09/2021 (08:39) 13/09/2021 08:39 ALMIRALL, S.A. On financial instruments Almirall, S.A. has decided to carry out an issuance of senior notes in an aggregate maximum principal amount of €250,000,000 due 2026 Register number: 11601 16/08/2021 07:54 ALMIRALL, S.A. On business and financial situation Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials Register number: 11305 26/07/2021 06:56 ALMIRALL, S.A. On corporate governance Comisión de Dermatología & Comisión de Nombramientos y Retribuciones Register number: 10795 Page 11 out of 18 «...1112131415...»
